James F. Crismale

James F. Crismale

Auto-generated profile, based on publicly available information

James F. Crismale

Recanati/Miller Transplantation Institute, The Mount Sinai Hospital, New York, NY, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2020 in Medical Clinics of North America
Verified
Journal Article
Closed access
JCJames F. Crismale
James F. Crismale
SFScott L. Friedman
Scott L. Friedman

6 December 2019 in Clinical Transplantation
Verified
Journal Article
Closed access
PDF file
JCJames F. Crismale
James F. Crismale
MKMian Khalid
Mian Khalid
ABArjun Bhansali
Arjun Bhansali
GBGraciela De Boccardo
Graciela De Boccardo
RKRafael Khaim
Rafael Khaim
TSThomas D. Schiano
Thomas D. Schiano

1 December 2020 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
BDBen L. Da
Ben L. Da
GEGhideon Ezaz
Ghideon Ezaz
TKTatyana Kushner
Tatyana Kushner
JCJames Crismale
James Crismale
GKGaurav Kakked
Gaurav Kakked
BSBehnam Saberi
Behnam Saberi
Despite an increase in the number of liver transplants (LTs) performed in the United States, the rate at which patients are placed on the waitlist continues to surpass the increased number of transplants, creating a significant mismatch between organ supply and demand.1 The use of hepatitis C virus (HCV)–positive organs has been widely adopted as one of the solutions to the major organ shortage by increasing the donor pool.2 Although HCV infection is estimated to affect 1% to 2% of the general US population, this risk is higher (3%-18%) among organ donors with increased risk as defined by the Public Health Service.3 In light of the ongoing opioid epidemic and the associated rise in drug overdose deaths, the number of Public Health Service “increased risk” HCV-positive organs available has been increasing rapidly.4,5

26 January 2018 in Hepatology Communications
Verified
Journal Article
Open access
PDF file
SSShazia Mehmood Siddique
Shazia Mehmood Siddique
MLMeghan Lane‐Fall
Meghan Lane‐Fall
MMMatthew J. McConnell
Matthew J. McConnell
NJNeha Jakhete
Neha Jakhete
JCJames Crismale
James Crismale
JSJudy A. Shea
Judy A. Shea
Patients with cirrhosis have high admission and readmission rates, and it is estimated that a quarter are potentially preventable. Little data are available regarding nonmedical factors impacting triage decisions in this patient population. This study sought to explore such factors as well as to determine provider perspectives on low‐acuity clinical presentations to the emergency department, including ascites and hepatic encephalopathy. A survey was distributed in four liver transplant centers to both emergency medicine and hepatology providers, who included attending physicians, house staff, and advanced practitioners; 196 surveys were returned (estimated response rate 50.6%). Emergency medicine providers identified several influential nonmedical factors impacting inpatient triage decisions, including input from a hepatologist (77.7%), inadequate patient access to outpatient specialty care (68.6%), and patient need for diagnostic testing for a procedure (65.6%). When given patient‐based scenarios of low‐acuity cases, such as ascites requiring paracentesis, only 7.0% believed patients should be hospitalized while 48.9% said these patients would be hospitalized at their institution (P < 0.0001). For mild hepatic encephalopathy, the comparable numbers were 19.5% and 55.2%, respectively (P < 0.001). Several perceived barriers were cited for this discrepancy, including limited resources both in the outpatient setting and emergency department. Most providers believed that an emergency department observation unit protocol would influence triage toward an emergency department observation unit visit instead of inpatient admission for both ascites requiring large volume paracentesis (83.2%) and mild hepatic encephalopathy (79.4%). Conclusion: Many nonmedical factors that influence inpatient triage for patients with cirrhosis could be targeted for quality improvement initiatives. In some scenarios, providers are limited by resource availability, which results in triage to an inpatient admission even when they believe this is not the most appropriate disposition. (Hepatology Communications 2018;2:237‐244)

23 June 2021 in Clinical Transplantation
Verified
Journal Article
Closed access
PDF file
JCJaclyn Chesner
Jaclyn Chesner
TSThomas D. Schiano
Thomas D. Schiano
MFM. Isabel Fiel
M. Isabel Fiel
JCJames F. Crismale
James F. Crismale

12 October 2020 in American Journal of Transplantation
Verified
Journal Article
Open access
PDF file
JCJames F. Crismale
James F. Crismale
DMDalia Mahmoud
Dalia Mahmoud
JMJang Moon
Jang Moon
MFM. Isabel Fiel
M. Isabel Fiel
KIKishore Iyer
Kishore Iyer
TSThomas D. Schiano
Thomas D. Schiano
Intestinal transplantation (ITx) is the treatment of choice for patients with intestinal failure who have developed life‐threatening complications related to long‐term parenteral nutrition. Patients may also undergo ITx as part of a combined liver‐intestine or multi‐visceral transplant for a variety of indications, most commonly intestinal failure‐associated liver disease or porto‐mesenteric thrombosis. Endoscopy plays a critical role in the post‐transplant management of these patients, most commonly in the diagnosis and management of rejection, which occurs in up to 30‐40% of patients within the first year post‐transplant. With a lack of noninvasive biomarkers to identify the presence of rejection, endoscopy and biopsy remain the gold‐standard for its diagnosis. Endoscopic evaluation of the graft is also important in the identification of other complications post‐ITx, including post‐transplant lymphoproliferative disorder, graft‐versus‐host disease, and enteric infections. Each patient’s post‐transplant anatomy may be slightly different, making endoscopy sometimes technically challenging and necessitating clear and frequent communication with the surgical team in order to help identify the highest‐yield approach. Herein, we review the most common pathologies found endoscopically in the post‐ITx patient and describe some of the unique challenges the endoscopist faces when evaluating these complex patients.